Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors (NCT07257484)
🩺 Plain-English Summary (8th-Grade Level)
This study will explore whether tirzepatide is a practical and acceptable treatment for postmenopausal females with a history of hormone receptor-positive breast cancer and obesity. The investigators aim to understand whether participants are willing and able to take this medication once weekly for 6 months and whether it may help improve weight and overall health. There will be monthly check-ins to monitor progress and safety. At the beginning and end of the study, participants will undergo body composition assessments, blood tests and a stool sample will be collected, and surveys will be completed.
Who can join: Review the eligibility criteria below.
Location: Weill Cornell Medicine — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Weill Cornell Medicine — New York, New York
📞 Contact the Study Coordinator
Phone: (646) 962-2423
Email: ljw4002@med.cornell.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity (Disorder)
- Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals. — Prairie View, Texas
- Iron Metabolism in Obesity — San Pedro Garza García, Nuevo León
- Continuous Glucose Monitoring in Metabolic Surgery — Baton Rouge, Louisiana
- Healthy Living Anson Study — Chapel Hill, North Carolina
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity — Hamilton, Ontario
- Repeated Far Infrared Sauna Bathing in Adults With Obesity — Eugene, Oregon
Explore by condition: All Obesity (Disorder) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.